JOHN FREDERICK BRANDSEMA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology PHILADELPHIA, PA NPI 1275889792
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology PA Genentech USA, Inc. All categories
General Payments — all program years on this page
$582,633.36
- Category: General Payments
- Program years: PY2018–2024
- Record count: 727
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $47,109.70 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $38,497.34 | 7 |
| Travel and Lodging | $3,611.84 | 16 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,208.17 | 2 |
| Food and Beverage | $1,778.86 | 22 |
| Education | $13.49 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $17,425.59 | 17 |
| Biogen, Inc. | $9,829.65 | 16 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $7,934.69 | 6 |
| PTC Therapeutics, Inc. | $4,387.50 | 1 |
| ITF Therapeutics LLC | $3,272.34 | 3 |
| UCB SA | $2,539.34 | 1 |
| ARGENX US, INC. | $1,662.50 | 1 |
| Genentech, Inc. | $31.46 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $13.49 | 1 |
| Sarepta Therapeutics, Inc. | $13.14 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.